Skip to main content

Your search for “Cannabis” returned 40 results

Altman Clinical and Translational Research Institute Building Opens March 4

February 29, 2016

Rising above Interstate 5 on the east campus of University of California, San Diego, the Altman Clinical and Translational Research Institute Building (ACTRI), a five-sided polygon of glass, steel and grooved concrete, officially opens its doors March 4 in a ribbon-cutting ceremony.

U.S. News & World Report: UC San Diego Graduate and Professional Schools are Nation’s Best

March 12, 2019

U.S. News & World Report today released its 2020 guidebook that ranks the nation’s top graduate programs and professional schools, giving high marks to UC San Diego’s innovative programs.

How the Brain Makes–and Breaks–a Habit

May 26, 2016

Not all habits are bad. Some are even necessary. But inability to switch from acting habitually to acting in a deliberate way can underlie addiction and obsessive compulsive disorders. Working with a mouse model, an international team of researchers demonstrates what happens in the brain for habits to control behavior

Large Study Identifies Genetic Variants Linked to Risk Tolerance and Risky Behaviors

January 14, 2019

An international group that includes researchers at University of California San Diego School of Medicine has identified 124 genetic variants associated with a person’s willingness to take risks, as reported in a study published January 14, 2019 in Nature Genetics.

New Report Creates Roadmap for U.S.-Mexico Cooperation on Security, Drug and Border Policy

April 16, 2019

The University of California San Diego School of Global Policy and Strategy’s Center for U.S.-Mexican Studies recently released a report listing steps the U.S. and Mexico can take to make each other safe. The white paper lists 13 recommendations for both nations to achieve bilateral cooperation.

Altman Clinical and Translational Research Building Makes Its Debut

March 10, 2016

…Study, the Center for Cannabis Research, the Type 1 Diabetes Research Center, the Musculoskeletal Science Center, the Center for Multimodal Imaging and Genomics and the departments of gastroenterology, hepatology and ophthalmology. “This is a 21st century lab,” said Dr. David Brenner, Vice Chancellor of Health Sciences and Dean of the…

Unregulated Sales of a Toxic and Hallucinogenic Mushroom Endanger Public Health

June 10, 2024

Americans’ interest in the potentially harmful “magic mushroom” Amanita muscaria is soaring, according to a new study. UC San Diego researchers suggest the market growth may be driven by clinical research on psilocybin’s safety and efficacy in treating depression.

Minding Time

April 18, 2019

…on HIV and medicinal cannabis. Read More… Nineteen-hundred-and-sixty-nine was a famously memorable year. It was the year of Woodstock and the first man on the moon, of the Cuyahoga River in Cleveland catching fire and the last public performance by The Beatles—an impromptu concert atop Apple Records in London. It…

Clinical Trial Evaluates Synthetic Cannabinoid as Brain Cancer Treatment

September 25, 2012

Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.

UC San Diego’s 2019 Entrepreneurs in Residence Program Is Largest Ever

November 6, 2019

The University of California San Diego has announced its 2019 Entrepreneurs in Residence cohort. The EIR program brings outside expertise onto campus to help student and faculty entrepreneurs with their startups.

Category navigation with Social links